1. Home
  2. TITN vs IMMP Comparison

TITN vs IMMP Comparison

Compare TITN & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Titan Machinery Inc.

TITN

Titan Machinery Inc.

HOLD

Current Price

$16.30

Market Cap

416.9M

ML Signal

HOLD

Logo Immutep Limited

IMMP

Immutep Limited

HOLD

Current Price

$0.40

Market Cap

410.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TITN
IMMP
Founded
1980
1987
Country
United States
Australia
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
416.9M
410.7M
IPO Year
2007
2012

Fundamental Metrics

Financial Performance
Metric
TITN
IMMP
Price
$16.30
$0.40
Analyst Decision
Hold
Hold
Analyst Count
4
3
Target Price
$21.50
$5.50
AVG Volume (30 Days)
130.8K
2.5M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,702,122,000.00
N/A
Revenue This Year
N/A
$382.75
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.50
$0.40
52 Week High
$21.75
$3.53

Technical Indicators

Market Signals
Indicator
TITN
IMMP
Relative Strength Index (RSI) 33.34 13.19
Support Level $15.32 N/A
Resistance Level $16.94 $1.90
Average True Range (ATR) 0.82 0.12
MACD -0.42 -0.27
Stochastic Oscillator 2.51 0.24

Price Performance

Historical Comparison
TITN
IMMP

About TITN Titan Machinery Inc.

Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through the following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.

About IMMP Immutep Limited

Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-004, TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

Share on Social Networks: